130 related articles for article (PubMed ID: 3156964)
1. EMD 23,448: effects of a putative dopamine autoreceptor agonist in chorea.
Newman RP; Tamminga CA; Chase TN; LeWitt PA
J Neural Transm; 1985; 61(1-2):125-9. PubMed ID: 3156964
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D-1 receptor agonist stimulation of prolactin secretion in man.
Fabbrini G; Braun A; Mouradian MM; Tamminga CA; Chase TN
J Neural Transm; 1988; 71(3):159-63. PubMed ID: 2965754
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone and prolactin release in Huntington's chorea.
Chalmers RJ; Johnson RH; Nanda RN
Lancet; 1977 Oct; 2(8042):824. PubMed ID: 71631
[No Abstract] [Full Text] [Related]
4. Altered growth hormone and prolactin responses to dopaminergic stimulation in Huntington's chorea.
Caraceni T; Panerai AE; Paratl EA; Cocchi D; Müller EE
J Clin Endocrinol Metab; 1977 May; 44(5):870-5. PubMed ID: 140180
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea.
Chalmers RJ; Johnson RH; Keogh HJ; Nanda RN
J Neurol Neurosurg Psychiatry; 1978 Feb; 41(2):135-9. PubMed ID: 24678
[TBL] [Abstract][Full Text] [Related]
6. Apomorphine hydrochloride-induced improvement in Huntington's chorea: stimulation of dopamine receptor.
Corsini GU; Onali P; Masala C; Cianchetti C; Mangoni A; Gessa G
Arch Neurol; 1978 Jan; 35(1):27-30. PubMed ID: 145840
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous nocturnal plasma prolactin and growth hormone secretion in patients with Parkinson's disease and Huntington's chorea.
Murri L; Iudice A; Muratorio A; Polleri A; Barreca T; Murialdo G
Eur Neurol; 1980; 19(3):198-206. PubMed ID: 6446454
[TBL] [Abstract][Full Text] [Related]
8. Plasma growth hormone and prolactin response to dopaminergic GABAmimetic and cholinergic stimulation in Huntington's disease.
Durso R; Tamminga CA; Denaro A; Ruggeri S; Chase TN
Neurology; 1983 Sep; 33(9):1229-32. PubMed ID: 6225034
[TBL] [Abstract][Full Text] [Related]
9. Prolactin control in Huntington's chorea.
Müller EE; Cocchi D; Mantegazza P; Parati EA; Caraceni T
Lancet; 1977 Oct; 2(8041):764-5. PubMed ID: 71573
[No Abstract] [Full Text] [Related]
10. [Huntington's chorea and somatotropic hormone: dynamic explorations in 27 cases (author's transl)].
Destée A; Petit H; Fossati P; Warot P
Rev Neurol (Paris); 1981; 137(1):21-31. PubMed ID: 6453416
[No Abstract] [Full Text] [Related]
11. Role of dopaminergic receptors in the regulation of growth hormone secretion.
Müller EE; Liuzzi A; Cocchi D; Panerai AE; Oppizzi G; Lacatelli V; Mantegazza P; Silvestrini F; Chiodini PG
Adv Biochem Psychopharmacol; 1977; 16():127-38. PubMed ID: 142419
[No Abstract] [Full Text] [Related]
12. Biochemical mechanisms and management of choreiform movement disorders.
de Silva L
Drugs; 1977 Oct; 14(4):300-10. PubMed ID: 144049
[No Abstract] [Full Text] [Related]
13. Treatment of Parkinson's disease with the partial dopamine agonist EMD 49980.
Bravi D; Davis TL; Mouradian MM; Chase TN
Mov Disord; 1993 Apr; 8(2):195-7. PubMed ID: 8097280
[TBL] [Abstract][Full Text] [Related]
14. Effects of apomorphine on blood levels of homovanillic acid, growth hormone and prolactin in medicated schizophrenics and healthy control subjects.
Scheinin M; Syvälahti EK; Hietala J; Huupponen R; Pihlajamäki K; Seppälä OP; Säkö E
Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):441-9. PubMed ID: 2866563
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic experience with transdihydrolisuride in Huntington's disease.
Bassi S; Albizzati MG; Corsini GU; Frattola L; Piolti R; Suchy I; Trabucchi M
Neurology; 1986 Jul; 36(7):984-6. PubMed ID: 2940475
[TBL] [Abstract][Full Text] [Related]
16. Effect of dopamine and neuroleptics on plasma growth hormone and prolactin in normal men.
Langer G; Sachar EJ; Halpern FS
Psychoneuroendocrinology; 1978 Apr; 3(2):165-9. PubMed ID: 704750
[No Abstract] [Full Text] [Related]
17. Electrophysiological studies on EMD 23 448, an indolyl-3-butylamine, in the rat: a putative selective dopamine autoreceptor agonist.
Chiodo LA; Bunney BS
Neuropharmacology; 1983 Sep; 22(9):1087-93. PubMed ID: 6138728
[TBL] [Abstract][Full Text] [Related]
18. The effect of buspirone on prolactin and growth hormone secretion in man.
Meltzer HY; Flemming R; Robertson A
Arch Gen Psychiatry; 1983 Oct; 40(10):1099-102. PubMed ID: 6138009
[TBL] [Abstract][Full Text] [Related]
19. The characterization of the dopaminergic profile of EMD 23,448, and indolyl-3-butylamine: selective actions on presynaptic and supersensitive postsynaptic DA receptor populations.
Goldstein M; Fuxe K; Meller E; Seyfried CA; Agnati L; Mascagni FM
J Neural Transm; 1987; 70(3-4):193-215. PubMed ID: 2890706
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of choreic syndromes with sodium dipropylacetate].
Piccinin G; Morocutti C; Urcioli R; Bernardi G
Riv Neurol; 1977; 47(2):107-16. PubMed ID: 141095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
